Embryonic and neonatal neurons require specific trophic supplements for their survival and the induction of transmitter-synthesizing enzymes in vivo and in vitro. Acidic and basic fibroblast growth factor (aFGF, bFGF) and the closely related astroglial growth factors AGF-1 and AGF-2 were studied for putative neurotrophic functions using dissociated, highly neuron-enriched cultures from chick and rat peripheral ganglia and central nervous system tissues. Embryonic chick ciliary ganglion neurons were the only peripheral neurons that responded to bFGF and AGF-2 by enhanced survival equivalent to that obtained with ciliary neurotrophic factor. Half-maximal effects were achieved with bFGF at 360 pg/ml or AGF-2 at 3 ng/ml. Small effects seen with aFGF could be potentiated by adding heparin at 1 ,ug/ml. bFGF, but not ciliary neurotropic factor, also promoted neuron survival after the factor was bound to polyornithine and laminin. Both AGF-2 and ciliary neurotropic factor induced choline acetyltransferase activity during 48 hr. AGFs and FGFs also enhanced the long-term survival of embryonic chick spinal cord neurons, including motoneurons that had been retrogradely labeled with rhodamine isothiocyanate. These results demonstrate the potency of a class of mitogenic growth factors as neurotrophic agents for embryonic ciliary ganglion and spinal cord neurons-adding to the emerging evidence that mitogenic and neuronal growth factors are not strictly separate entities.
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Mitogenic, growth-promoting factors for cells derived from the mesoderm (e.g., fibroblast growth factors, FGFs) and neurotrophic factors (the prototype of which is nerve growth factor) that promote survival, differentiation, and functional maintenance of neurons have long been considered as separate entities. Emerging evidence suggests that this view can no longer strictly be maintained. Thus, nerve growth factor has been shown to act as a mitogen on rat pheochromocytoma (1) and adrenal medullary chromaffin cells (2) . On the other hand, FGF and astroglial growth factors (AGF-1 and -2) that are closely related or even identical to acidic and basic FGF (aFGF, bFGF) (3) induce proliferation and differentiation of neuroectodermal astroglial cells (4) , oligodendrocytes (5, 6) , and neuron-like PC-12 pheochromocytoma cells (7) .
Large amounts of FGF are found in brain (8) (9) (10) , and immunocytochemical studies using antibodies to AGF/FGF have revealed their localization in neurons of the central nervous system (11) . We therefore questioned whether AGF and FGF had functions in the nervous system in addition to their established role for glial cells.
We provide evidence that AGF and FGF mimic two effects typical of neurotrophic factors-promotion of in vitro neuron survival and enhancement of the activity of a transmittersynthesizing enzyme, choline acetyltransferase (ChoAcTase, acetyl-CoA:choline O-acetyltransferase, EC 2.3.1.6)-in peripheral and central nervous system neurons. Some of these results have previously been published in abstract form (12, 13) . While this work was in progress, two groups (14, 15) reported a survival-promoting effect of FGF for dissociated rat hippocampal and cortical neurons in vitro.
MATERIALS AND METHODS Growth Factors. fl-nerve growth factor was isolated from submaxillary glands of male mice and tested for biological activity as reported (16) . Ciliary neurotrophic factor (CNTF) was purified according to a reported method (17) , and AGF-1 and AGF-2 were purified from bovine brain by heparinSepharose affinity chromatography and Pro-reversed-phase chromatography (3). Basic and aFGF were gifts from D. Gospodarowicz, University of California Medical School (San Francisco).
Neuronal Cell Cultures. Assays were done using cultures of the following neuron populations: embryonic day (E)-8 chick ciliary ganglia, E-8 and E-10 chick dorsal root ganglia, E-11 chick lumbar sympathetic ganglia, E-6 chick lumbar spinal cord (ventral halves), E-18 rat hippocampus, newborn rat superior cervical ganglia, and newborn rat nodose ganglia. Ganglia and central nervous system tissues were dissected and dissociated basically following methods described (17) (18) (19) . Culture plates of 96 wells were prepared by treating the wells in succession with 50 ,ul of poly(L-a-ornithine) hydrogen bromide [poly(Orn); 0.1 mg/ml in 15 mM borate buffer, pH 8.4; Sigma, Munich, F.R.G.] for 2 hr followed by three washes with distilled water (Milli-Q-System) and incubation overnight with (i) Dulbecco's modified Eagle's medium (DMEM) or (ii) 5 
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44.4 mM NaHCO3, 2 mM glutamine, and 100 units of penicillin per ml for peripheral neurons. Culture media were further supplemented with 10% (vol/vol) heat-inactivated fetal calf serum (FCS) or the defined N1 additives (20) to which 0.25% bovine serum albumin (BSA) was added (HEBM/N1+BSA). Cell yields were as described previously (17) (18) (19) (Fig. 2 ), but these growth factors failed to support any other peripheral neuron studied. AGF-1 and aFGF had only a small effect without reaching a plateau when applied at the same concentration range (Fig. 2) . Fig. 2 illustrates dose-response behaviors of ciliary ganglion neurons toward the factors and compares them with CNTF. Saturating concentrations of AGF-2 and bFGF supported neurons at a plateau identical to that seen with CNTF. Half-maximal effects were achieved with AGF-2 at 3 ng/ml or bFGF at 360 pg/ml, respectively. There were no overt differences in survival depending on whether neurons were maintained on poly(Orn) or poly(Orn) coated with laminin. Neuritic growth, however, was clearly facilitated on laminin as compared with poly(Orn) (cf. and bFGF appeared to have an enhancing effect with respect to both average neurite length and percentages of neuritebearing cells. No attempts were made to quantify these differences.
Effects of FGF on the elaboration of neurites have earlier been seen (cf. refs. 14 and 15) on cultured hippocampal and cortical neurons treated with FGF. Replacing serum in the culture medium by the defined N1 supplement did not alter the survival-promoting effects (ED50) of AGF-2 and bFGF, suggesting that the serum used did not contain components that impaired or synergistically enhanced the potency of these agents. To clearly ascertain that the effects resulted from a direct action of growth factors on neurons rather than an indirect nonneuronal cell-mediated influence, we established neuron-enriched cultures of ciliary ganglionic cell suspension. "Flat", or nonneuronal, cells were consistently reduced by 20-30% in number after 24 hr in serum-free culture. This observation coupled with the calculation of 700- trophic factors from the remaining nonneuronal cells (see Discussion) make it unlikely that neuronal survival with AGF and FGF was an indirect effect (i.e., mediated by nonneuronal cells). AGF-2 and bFGF maintained neurons in serum-free culture over 7 days at numbers identical to those achieved with CNTF; the portion of nonneuronal cells in these cultures was <20%. Heparin increases the biological activity of FGF on several nonneuronal cell targets (10) . Addition of heparin at 1 ,ug/ml to aFGF at concentrations shown to exert little effect on ciliary ganglion neurons (see above) potentiated the survivalpromoting activity of aFGF %100-fold (Fig. 3) . At 10 or 0.1 ,ug per ml, heparin had no or little effect, respectively, on the survival-promoting activity of aFGF.
That FGF and related heparin-binding growth factors might exert their effects while bound to components of the extracellular matrix has been discussed (26) . When bFGF was adsorbed to poly(Orn) or poly(Orn)/laminin surfaces overnight and unattached material was removed by extensive washing, ciliary ganglion neurons survived on the pretreated substrata in the absence of added trophic factors. Doseresponse curves (Fig. 4) established half-maximal effects at 5 ng per 6-mm well. In control experiments attempts were made to adsorb nerve growth factor or CNTF to poly(Orn) and poly(Orn)/laminin. Both factors, however, did not bind or, if bound, failed to promote neuronal survival under these conditions.
AGFs and FGFs Promote Survival of Chick Spinal Cord Neurons. Neuron-enriched cultures of E-5.5-E-6 chick embryo spinal cord containing about 85% cells with tetanus toxin-binding sites could be maintained for an initial period of 2-3 days in DMEM plus 10% FCS with neuronal number remaining constant in the absence or presence, respectively, of AGFs or FGFs. After day 3, however, neurons survived better with than without AGFs and FGFs (Figs. 5 and 6 A and B). With 2000 preplated cells seeded per well, 47 ± 6 (mean -± SD, n = 3) neurite-bearing cells were present at day 7 in cultures maintained with DMEM/10% FCS. Neurons did not survive when HEBM/N1 + BSA was used as a culture medium. Addition of saturating concentrations (20 ng/ml) of AGFs or FGFs, respectively, maintained between 430 and 510 neurons. Dose-response curves are shown in Fig. 5 ; ED50 values are 0.8-2 ng/ml for AGFs and FGFs. At least 95% of the cells in these cultures (without FCS) bound tetanus toxin after 7 days (Fig. 6C) . Most neurons were multipolar; some had one particularly long neurite (>200 ,m; Fig. 6A ). To investigate whether motoneurons were preferentially supported by the trophic factors motoneurons were retrogradely labeled with rhodamine isothiocyanate (Figs. 6 D-G) . Evaluation of these cultures was difficult because the rhodamine label had faded considerably by day 4 when the differences in neuronal cell numbers of cultures maintained with or without factors became significant. Table 1 presents results from three experiments; the slight increase seen in the proportion of labeled (moto-)neurons in cultures treated with 20 ng/ml of bFGF was not statistically significant.
AGF and FGF Induce ChoAcTase Activity. Ciliary ganglion neurons were used to find whether AGF-2, in addition to its survival-promoting effect, also could induce the activity of the acetylcholine-synthesizing enzyme ChoAcTase. ChoAcTase activity was determined in neuron-enriched cell suspension dissociated from E-8 and E-10 ganglia as well as in neuron-enriched cultures from E-8 ganglia kept for 2 days in the presence or absence, respectively, of AGF-2 at 10 ng/ml or CNTF at 10 ng/ml (Table 2) . Treatment with either factor caused an increase of ChoAcTase activity. The increase was >3-fold with AGF-2 inducing ChoAcTase activity at a level exceeding the enzyme activity of ganglia dissociated at E-10. CNTF-induced ChoAcTase activity was more modest, not reaching the E-10 value.
DISCUSSION
AGF and FGF, proteins with established mitogenic and differentiation-promoting effects for glial cells and derivatives of mesoderm origin (3) (4) (5) (6) 10) , were found also to be trophic for neurons cultured from embryonic peripheral and central nervous systems. Neurotrophic actions comprised (i) promotion of survival, (ii) neuritic growth, and (iii) induction of transmitter-synthesizing enzyme ChoAcTase activity.
AGF and FGF are probably closely related, or are even identical proteins. AGF-1 and AGF-2 have been purified from bovine brain (3) and found to have amino acid compositions similar to those of aFGF and bFGF, respectively. A monoclonal antibody raised against AGF-2 recognizes both AGF-2 and bFGF (11) . Similarities of AGFs and FGFs in biological functions include (i) growth-and differentiation-promoting 0 ,w500- effects for cultured astroglial cells (3, 27) , (ii) identical neuronal target cells, and (iii) similar, but not identical, potency. We found bFGF to be -5-10 times more potent than AGF-2 on ciliary ganglion neurons, but not on spinal cord neurons. This discrepancy might be due to differences in the tertiary structure of the native molecules. Halfmaximal and minimal-effective doses of bFGF that affect ciliary ganglion neurons are consistent with respective doses reported for hippocampal neurons (14) and concentrations required for inducing mitoses in cultured endothelial cells (28, 29) .
AGF-1/aFGF and AGF-2/bFGF were equally potent in maintaining survival of spinal cord neurons, but differed in The ability of bFGF to promote survival after being bound to the substrates poly(Orn) or poly(Orn)/laminin distinguishes it from nerve growth factor and CNTF, both of which were ineffective under identical conditions. The observation is reminiscent of an experiment where FGF bound to poly-(Orn)/heparin or to plastic promoted neurite outgrowth of hippocampal neurons (14) . FGF may be adsorbed to components of the extracellular matrix (26) , but in this form may not be active as a mitogen because immobilization of FGF would prevent microaggregation of FGF receptor complexes, a prerequisite for mitogenesis (10) . CNTF has been shown to maintain its survival-supporting abilities for ciliary ganglion neurons when bound to nitrocellulose paper (31) . In our study the fraction of FGF actually bound was not determined, nor do our data allow us to conclude whether an immobilized or redissolved FGF bound to the ciliary ganglion neurons. Experiments using radioiodinated, biologically active FGF adsorbed to different substrates are required to elucidate how FGF exerts its effects on neuronal targets in vivo.
The presence of large quantities of AGF/FGFs in brain (3, 10) seems compatible with speculations about their effects on central nervous system neurons. Studies to reveal a physiological role of FGF in the brain would include demonstration of its binding to specific receptors, retrograde axonal transport techniques, and administration of its antibodies. The effect of FGF on ciliary ganglion neurons, the only peripheral neuron population affected, might be compatible with the idea of ciliary neuron projections to the eye, a rich source of FGF (32) (33) (34) . This logic, however, does not completely satisfy, because superior cervical ganglion and sensory neurons supplying various ocular tissues were not responsive to FGF.
Before further considerations concerning the specificity of FGF for distinct neuronal target cells and corresponding in vivo sources of FGF one has to remember that release of FGF from intact cells has not been reported. Several lines of evidence suggest that FGF may be predominantly, if not exclusively, liberated from injured tissues, macrophages (35) , and lysed mesenchymal stroma during development (10) . The noncompartmentalized storage form of FGF immunoreactivity in the neuronal cytosol (11) also suggests that FGF is not readily released from neurons. It would therefore seem that FGF is presented to neurons in vivo after liberation from cells that are undergoing lesion-induced or developmentally regulated cell death.
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